Literature DB >> 34840874

Impact of ICD-9 to ICD-10 Coding Transition on Prevalence Trends in Neurology.

Ali G Hamedani1, Leah Blank1, Dylan P Thibault1, Allison W Willis1.   

Abstract

OBJECTIVE: To determine the effect of International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) to International Classification of Diseases, 10th Revision, Clinical Modification (ICD-10-CM) coding transition on the point prevalence and longitudinal trends of 16 neurologic diagnoses.
METHODS: We used 2014-2017 data from the National Inpatient Sample to identify hospitalizations with one of 16 common neurologic diagnoses. We used published ICD-9-CM codes to identify hospitalizations from January 1, 2014, to September 30, 2015, and used the Agency for Healthcare Research and Quality's MapIt tool to convert them to equivalent ICD-10-CM codes for October 1, 2015-December 31, 2017. We compared the prevalence of each diagnosis before vs after the ICD coding transition using logistic regression and used interrupted time series regression to model the longitudinal change in disease prevalence across time.
RESULTS: The average monthly prevalence of subarachnoid hemorrhage was stable before the coding transition (average monthly increase of 4.32 admissions, 99.7% confidence interval [CI]: -8.38 to 17.01) but increased after the coding transition (average monthly increase of 24.32 admissions, 99.7% CI: 15.71-32.93). Otherwise, there were no significant differences in the longitudinal rate of change in disease prevalence over time between ICD-9-CM and ICD-10-CM. Six of 16 neurologic diagnoses (37.5%) experienced significant changes in cross-sectional prevalence during the coding transition, most notably for status epilepticus (odds ratio 0.30, 99.7% CI: 0.26-0.34).
CONCLUSIONS: The transition from ICD-9-CM to ICD-10-CM coding affects prevalence estimates for status epilepticus and other neurologic disorders, a potential source of bias for future longitudinal neurologic studies. Studies should limit to 1 coding system or use interrupted time series models to adjust for changes in coding patterns until new neurology-specific ICD-9 to ICD-10 conversion maps can be developed.
© 2021 American Academy of Neurology.

Entities:  

Year:  2021        PMID: 34840874      PMCID: PMC8610531          DOI: 10.1212/CPJ.0000000000001046

Source DB:  PubMed          Journal:  Neurol Clin Pract        ISSN: 2163-0402


  17 in total

1.  Continuous EEG is associated with favorable hospitalization outcomes for critically ill patients.

Authors:  Chloe E Hill; Leah J Blank; Dylan Thibault; Kathryn A Davis; Nabila Dahodwala; Brian Litt; Allison W Willis
Journal:  Neurology       Date:  2018-11-30       Impact factor: 9.910

2.  Sociodemographic Factors Associated With Hospital Care for Pediatric Migraine: A National Study Using the Kids' Inpatient Dataset.

Authors:  Ana Recober; Payal B Patel; Dylan P Thibault; Andrew W Hill; Eric A Kaiser; Allison W Willis
Journal:  Pediatr Neurol       Date:  2018-02-01       Impact factor: 3.372

3.  Assessing validity of ICD-9-CM and ICD-10 administrative data in recording clinical conditions in a unique dually coded database.

Authors:  Hude Quan; Bing Li; L Duncan Saunders; Gerry A Parsons; Carolyn I Nilsson; Arif Alibhai; William A Ghali
Journal:  Health Serv Res       Date:  2008-08       Impact factor: 3.402

4.  Estimating the cost of status epilepticus admissions in the United States of America using ICD-10 codes.

Authors:  Iván Sánchez Fernández; Marta Amengual-Gual; Cristina Barcia Aguilar; Tobias Loddenkemper
Journal:  Seizure       Date:  2019-09-04       Impact factor: 3.184

5.  Temporal Trends of Pediatric Hospitalizations with Acute Disseminated Encephalomyelitis in the United States: An Analysis from 2006 to 2014 using National Inpatient Sample.

Authors:  Parth Bhatt; Leonita Bray; Sneha Raju; Fredrick Dapaah-Siakwan; Achint Patel; Riddhi Chaudhari; Keyur Donda; Neel S Bhatt; Mihir Dave; Vijay Gandhi Linga; Anusha Lekshminarayanan; Samir V Patel; Zeenia C Billimoria; Samuel Zuckerman; Priyank Yagnik; Dinesh Singh
Journal:  J Pediatr       Date:  2018-12-06       Impact factor: 4.406

6.  Hospital care for mental health and substance abuse conditions in Parkinson's disease.

Authors:  Allison W Willis; Dylan P Thibault; Peter N Schmidt; E Ray Dorsey; Daniel Weintraub
Journal:  Mov Disord       Date:  2016-12       Impact factor: 10.338

7.  Readmissions After Mechanical Thrombectomy for Acute Ischemic Stroke in the United States: A Nationwide Analysis.

Authors:  Preethi Ramchand; Dylan P Thibault; James A Crispo; Joshua Levine; Robert Hurst; Michael T Mullen; Scott Kasner; Allison W Willis
Journal:  J Stroke Cerebrovasc Dis       Date:  2018-07-02       Impact factor: 2.136

8.  Incidence and mortality rates of myasthenia gravis and myasthenic crisis in US hospitals.

Authors:  A Alshekhlee; J D Miles; B Katirji; D C Preston; H J Kaminski
Journal:  Neurology       Date:  2009-05-05       Impact factor: 9.910

9.  Comparing chronic condition rates using ICD-9 and ICD-10 in VA patients FY2014-2016.

Authors:  Jean Yoon; Adam Chow
Journal:  BMC Health Serv Res       Date:  2017-08-17       Impact factor: 2.655

10.  Interrupted time series design to evaluate the effect of the ICD-9-CM to ICD-10-CM coding transition on injury hospitalization trends.

Authors:  Svetla Slavova; Julia F Costich; Huong Luu; Judith Fields; Barbara A Gabella; Sergey Tarima; Terry L Bunn
Journal:  Inj Epidemiol       Date:  2018-10-01
View more
  2 in total

1.  Development and Validation of a Functionally Relevant Comorbid Health Index in Adults Admitted to Inpatient Rehabilitation for Traumatic Brain Injury.

Authors:  Raj G Kumar; Xiaobo Zhong; Gale G Whiteneck; Madhu Mazumdar; Flora M Hammond; Natalia Egorova; Kirk Lercher; Kristen Dams-O'Connor
Journal:  J Neurotrauma       Date:  2021-11-24       Impact factor: 5.269

2.  Factors Influencing Background Incidence Rate Calculation: Systematic Empirical Evaluation Across an International Network of Observational Databases.

Authors:  Anna Ostropolets; Xintong Li; Rupa Makadia; Gowtham Rao; Peter R Rijnbeek; Talita Duarte-Salles; Anthony G Sena; Azza Shaoibi; Marc A Suchard; Patrick B Ryan; Daniel Prieto-Alhambra; George Hripcsak
Journal:  Front Pharmacol       Date:  2022-04-26       Impact factor: 5.988

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.